Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Editas Medicine Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
EDIT
Nasdaq
2836
https://www.editasmedicine.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Editas Medicine Inc
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
- Mar 7th, 2024 8:31 am
Insider Sells Shares of Editas Medicine Inc (EDIT)
- Mar 6th, 2024 4:52 am
1 Beaten-Down Stock With 55% Upside, According to Wall Street
- Mar 4th, 2024 3:30 pm
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
- Mar 3rd, 2024 2:49 am
Editas Medicine, Inc. (NASDAQ:EDIT) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
- Mar 2nd, 2024 12:02 pm
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 4:26 pm
Editas (EDIT) Q4 Earnings & Revenues Top Estimates, Stock Up
- Feb 29th, 2024 1:42 pm
Q4 2023 Editas Medicine Inc Earnings Call
- Feb 29th, 2024 4:15 am
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
- Feb 28th, 2024 1:10 pm
Editas Medicine Inc (EDIT) Reports Improved Financials and Advances in Gene Editing Trials
- Feb 28th, 2024 12:35 pm
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
- Feb 28th, 2024 12:00 pm
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
- Feb 21st, 2024 12:00 pm
Wall Street Analysts Believe Editas (EDIT) Could Rally 80%: Here's is How to Trade
- Feb 19th, 2024 2:55 pm
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
- Feb 14th, 2024 11:00 am
5 Biotech Stocks to Consider for Your Portfolio in 2024
- Feb 13th, 2024 2:00 pm
Top 11 CRISPR Stocks To Invest In
- Feb 10th, 2024 10:09 pm
What Makes Editas (EDIT) a New Buy Stock
- Feb 6th, 2024 5:00 pm
Editas Medicine to Participate in Upcoming Investor Conferences
- Jan 31st, 2024 2:00 pm
2 Under-the-Radar Stocks With Incredible Upside Potential
- Jan 28th, 2024 1:45 pm
Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three years ago
- Jan 25th, 2024 11:48 am
Scroll